TLR Activation and Allergic Disease: Early Life Microbiome and Treatment

Curr Allergy Asthma Rep. 2018 Sep 26;18(11):61. doi: 10.1007/s11882-018-0815-5.

Abstract

Purpose of review: Allergy and asthma are growing problems in the developed world. The accelerated increase of these diseases may be related to microbiome modification that leads to aberrant activation of Toll-like receptors (TLRs). Current research supports the concept that changes in microbial communities in early life impact TLR activation, resulting in an altered risk for the development of asthma and allergies.

Recent findings: Prenatal and early childhood events that generate microbiome modification are closely related with TLR activation. Early childhood exposure to a rich array of TLR agonists, particularly lipopolysaccharide, strongly predicts protection against allergic disease later in life even when other lifestyle factors are accounted for. Genetic deletion of TLR signaling components in mice results in reduced function of tolerogenic cell populations in the gut. In contrast, weak TLR signaling can promote allergic sensitization later in life. This review summarizes the role of TLR signaling in microbiome-mediated protection against allergy.

Keywords: Allergy; Asthma; Microbiome; TLR sensitization; TLRs; Tolerogenic DC; Tregs.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Hypersensitivity* / drug therapy
  • Hypersensitivity* / immunology
  • Hypersensitivity* / microbiology
  • Microbiota*
  • Signal Transduction
  • Toll-Like Receptors / immunology*

Substances

  • Toll-Like Receptors